CSIMarket Company Name, Ticker, Customers, else..
 
Lb Pharmaceuticals Inc  (NASDAQ: LBRX)
 
Price: $37.5550 $0.28 0.738%
Day's High: $37.877498626708984 Week Perf: -0.65 %
Day's Low: $ 37.34 30 Day Perf: -20.54 %
Volume (M): 30,085 52 Wk High: $ 50.16
Volume (M$): $ 0 52 Wk Avg: $27.85
Open: $37.61 52 Wk Low: $14.32



 Market Capitalization (Millions $) 1,132
 Shares Outstanding (Millions) 30
 Employees 27
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -61
 Cash Flow (TTM) (Millions $) 317
 Capital Exp. (TTM) (Millions $) 0

Business Description


LB Pharmaceuticals Inc. is a late-stage biopharmaceutical company focused on developing therapies for neuropsychiatric disorders, including schizophrenia, bipolar depression, and adjunctive treatment of major depressive disorder. Their lead product candidate is LB-102.


   Company Address: One Pennsylvania Plaza New York 10119 NY
   Company Phone Number: 605-0300   Stock Exchange / Ticker: NASDAQ LBRX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Navigating the Regulatory Maze LB Pharmaceuticals Welcomes Dr. James Rawls as Senior Vice President of Regulatory Aff...

Published Tue, Oct 14 2025 1:29 PM UTC

In a strategic move poised to enhance its regulatory prowess, LB Pharmaceuticals Inc. (Nasdaq: LBRX), a forward-thinking biopharmaceutical company focused on developing treatments for neuropsychiatric diseases, has announced the appointment of Dr. James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs. This pivotal addition to the executive team reflects the c...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 3.41
PEG (TTM) -

Financial Strength Current
Quick Ratio 15.32
Working Capital Ratio 15.32
Leverage Ratio (MRQ) 0.09
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.29 $
Revenues (TTM) -
Cash Flow (TTM) 10.53 $
Cash 12.26 $
Book Value 11.03 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,240,970
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.